1. Appropriate vs. inappropriate antimicrobial therapy
P.G. Davey, C. Marwick 
Clinical Microbiology and Infection 
Volume 14, Pages (April 2008)
DOI: /j x
Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

2. Fig. 1
Inappropriate antimicrobial treatment and mortality rates with common bloodstream infection pathogens. Reproduced with permission from Ibrahim et al. [3]. CNS, coagulase-negative staphylococci; MRSA, methicillin-sensitive Staphylococcus aureus; MSSA, methicillin-sensitive S. aureus; VRE, vancomycin-resistant enterococci; E. coli, Escherichia coli; P. aeruginosa, Pseudomonas aeruginosa.
Clinical Microbiology and Infection  , 15-21DOI: ( /j x)
Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

3. Fig. 2
Classification and regression tree (CART) analysis of predictors of infection-related mortality in Staphylococcus aureus bacteraemia. Reproduced with permission from Lodise et al. [4]. APACHE II, acute physiology and chronic health evaluation; D-Tx, delayed treatment; E-Tx, early treatment; SAB, S. aureus bacteraemia.
Clinical Microbiology and Infection  , 15-21DOI: ( /j x)
Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions

4. Fig. 3
Odds ratio of fatality related to inappropriate empiricaltreatment and other demographic, physiological and microbiological risk-factors [5].
Clinical Microbiology and Infection  , 15-21DOI: ( /j x)
Copyright © 2008 European Society of Clinical Infectious Diseases Terms and Conditions